Adrenal disease

Accurate diagnosis of congenital adrenal hyperplasia due to CYP21A2 variants requires promoter analysis

Eur J EndocrinolPublished Observational cohort study

Authors' conclusion

Non-benign promoter variants occur frequently in individuals with 21-OHD and clinically unaffected carriers. Promoter variants can aggravate clinical presentation in 21-OHD and can explain cases with discrepant genotype and phenotype. Inclusion of CYP21A2 promoter analysis in diagnostic procedures can improve accuracy of diagnosis, management and genetic counseling in patients with 21-OHD and their families.

Study context

Population
Individuals undergoing routine diagnostic CYP21A2 genotyping including promoter analysis, tertiary referral center
Participants
1,279 individuals
Outcome
Frequency and type of CYP21A2 promoter variants and their influence on 21-OHD phenotype
Methodological detailsretrospective clinical/biochemical data collection, tertiary referral center and accredited genetic laboratory
  • Retrospective clinical/biochemical data collection
  • Tertiary referral center and accredited genetic laboratory

Main finding

As reported in the abstract

CYP21A2 promoter variants
Individuals with promoter variants
89 (7.0%)
Patients with 21-OHD (n = 207) with promoter variants
12.1%
Large conversion incl. promoter (c.-126C>T, c.-113G>A, c.-110T>C, c.-103A>G) and p.(Pro31Leu) in exon 1; mostly simply virilizing phenotype in trans with another classic allele
21 patients
Promoter variants in congenital adrenal hyperplasia (CAH) patients with only 1 known pathogenic variant
4
Promoter variants in clinically unaffected individuals with no other CYP21A2 variant
6
Conventional sequencing without promoter would not have suggested CAH or 21-OHD carrier status
10

Observational data: associations, not effects.

Original publication

Accurate diagnosis of congenital adrenal hyperplasia due to CYP21A2 variants requires promoter analysis. Eur J Endocrinol. Published 19 October 2025. doi:10.1093/ejendo/lvaf217

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.